Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 May;83(5):1472–1476. doi: 10.1172/JCI114040

Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.

F A Plummer 1, J N Simonsen 1, H Chubb 1, L Slaney 1, J Kimata 1, M Bosire 1, J O Ndinya-Achola 1, E N Ngugi 1
PMCID: PMC303849  PMID: 2496142

Abstract

We tested the hypothesis that strain-specific immunity occurs after gonococcal infection in a longitudinal study of 227 prostitutes resident in one small community who experienced frequent gonococcal infections. Women were examined and cultured for Neisseria gonorrhoeae at 2-wk intervals. Gonococcal isolates were typed according to protein 1 serovar, auxotype, and beta-lactamase plasmid type, and classified as to serovar and strain. The hypothesis was tested by comparing the predictions of the hypothesis with the observations of the study. Over the 14-mo period of the study, major changes in the prevalence of specific serovars were observed in the gonococcal population infecting these women. Women with HIV infection experienced a higher rate of gonococcal infection (0.56 +/- 0.03 vs. 0.46 +/- 0.04, P less than 0.05, t test) compared with HIV-negative women and were more likely to experience multiple infections with the same strain. The duration of prostitution was inversely related to the frequency of gonococcal infection. Women experiencing an infection with a specific gonococcal serovar were at a 2- to 10-fold reduced risk of reinfection with the same serovar, except for the 1B-1 serovar. The results of the study were consistent with all four predictions of the hypothesis. Infection with a specific gonococcal serovar results in specific but incomplete protection against subsequent infection with the homologous serovar. The mechanism of this protection remains to be determined.

Full text

PDF
1472

Images in this article

1475Image
on p.1475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchanan T. M., Eschenbach D. A., Knapp J. S., Holmes K. K. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):978–980. doi: 10.1016/0002-9378(80)91091-1. [DOI] [PubMed] [Google Scholar]
  2. Buchanan T. M., Pearce W. A. Pili as a mediator of the attachment of gonococci to human erythrocytes. Infect Immun. 1976 May;13(5):1483–1489. doi: 10.1128/iai.13.5.1483-1489.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Catlin B. W. Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing. J Infect Dis. 1973 Aug;128(2):178–194. doi: 10.1093/infdis/128.2.178. [DOI] [PubMed] [Google Scholar]
  4. D'Costa L. J., Plummer F. A., Bowmer I., Fransen L., Piot P., Ronald A. R., Nsanze H. Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis. 1985 Apr-Jun;12(2):64–67. doi: 10.1097/00007435-198504000-00002. [DOI] [PubMed] [Google Scholar]
  5. Danielsson D., Bygdeman S., Kallings I. Epidemiology of gonorrhoea: serogroup, antibiotic susceptibility and auxotype patterns of consecutive gonococcal isolates from ten different areas of Sweden. Scand J Infect Dis. 1983;15(1):33–42. doi: 10.3109/inf.1983.15.issue-1.07. [DOI] [PubMed] [Google Scholar]
  6. Gotschlich E. C. Development of a gonorrhoea vaccine: prospects, strategies and tactics. Bull World Health Organ. 1984;62(5):671–680. [PMC free article] [PubMed] [Google Scholar]
  7. Hook E. W., 3rd, Olsen D. A., Buchanan T. M. Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect Immun. 1984 Feb;43(2):706–709. doi: 10.1128/iai.43.2.706-709.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Knapp J. S., Tam M. R., Nowinski R. C., Holmes K. K., Sandström E. G. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis. 1984 Jul;150(1):44–48. doi: 10.1093/infdis/150.1.44. [DOI] [PubMed] [Google Scholar]
  9. Kreiss J. K., Koech D., Plummer F. A., Holmes K. K., Lightfoote M., Piot P., Ronald A. R., Ndinya-Achola J. O., D'Costa L. J., Roberts P. AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med. 1986 Feb 13;314(7):414–418. doi: 10.1056/NEJM198602133140704. [DOI] [PubMed] [Google Scholar]
  10. La Scolea L. J., Jr, Young F. E. Development of a defined minimal medium for the growth of Neisseria gonorrhoeae. Appl Microbiol. 1974 Jul;28(1):70–76. doi: 10.1128/am.28.1.70-76.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lammel C. J., Sweet R. L., Rice P. A., Knapp J. S., Schoolnik G. K., Heilbron D. C., Brooks G. F. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis. 1985 Nov;152(5):990–1001. doi: 10.1093/infdis/152.5.990. [DOI] [PubMed] [Google Scholar]
  12. Plummer F. A., Brunham R. C. Gonococcal recidivism, diversity, and ecology. Rev Infect Dis. 1987 Jul-Aug;9(4):846–850. doi: 10.1093/clinids/9.4.846. [DOI] [PubMed] [Google Scholar]
  13. Rothenberg R. B. The geography of gonorrhea. Empirical demonstration of core group transmission. Am J Epidemiol. 1983 Jun;117(6):688–694. doi: 10.1093/oxfordjournals.aje.a113602. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES